Celontin Side Effects

Generic Name: methsuximide

Please note - some side effects for Celontin may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Celontin - for the Consumer

Celontin

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Celontin:

Confusion; constipation; diarrhea; dizziness; drowsiness; headache; incoordination; loss of appetite; nausea; sleeplessness; stomach pain; vomiting; weight loss.

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bizarre or aggressive behavior; blurred vision or other vision changes; clumsiness; depression; fever, chills, or sore throat; hallucinations; mood or mental changes; red, swollen, or blistered skin; sensitivity to light; suicidal thoughts or behavior.

Celontin Side Effects - for the Professional

Celontin

Gastrointestinal System: Gastrointestinal symptoms occur frequently and have included nausea or vomiting, anorexia, diarrhea, weight loss, epigastric and abdominal pain, and constipation.

Hemopoietic System: Hemopoietic complications associated with the administration of methsuximide have included eosinophilia, leukopenia, monocytosis, and pancytopenia with or without bone marrow suppression.

Nervous System: Neurologic and sensory reactions reported during therapy with methsuximide have included drowsiness, ataxia or dizziness, irritability and nervousness, headache, blurred vision, photophobia, hiccups, and insomnia. Drowsiness, ataxia, and dizziness have been the most frequent side effects noted. Psychologic abnormalities have included confusion, instability, mental slowness, depression, hypochondriacal behavior, and aggressiveness. There have been rare reports of psychosis, suicidal behavior, and auditory hallucinations.

Integumentary System: Dermatologic manifestations which have occurred with the administration of methsuximide have included urticaria, Stevens-Johnson syndrome, and pruritic erythematous rashes.

Cardiovascular: Hyperemia.

Genitourinary System: Proteinuria, microscopic hematuria.

Body as a Whole: Periorbital edema.

Side Effects by Body System

Ocular

Ocular side effects have included periorbital edema.

Genitourinary

Genitourinary side effects have included proteinuria and microscopic hematuria.

Cardiovascular

Cardiovascular side effects have included hyperemia.

Dermatologic

Dermatologic side effects have included urticaria, Stevens-Johnson syndrome, and pruritic erythematous rashes.

Nervous system

Nervous system side effects have included drowsiness, ataxia or dizziness, irritability and nervousness, headache, blurred vision, photophobia, hiccups, and insomnia.

Psychiatric

Psychiatric side effects have included confusion, instability, mental slowness, depression, hypochondriacal behavior, and aggressiveness. There have also been rare reports of psychosis, suicidal behavior, and auditory hallucinations.

Hematologic

Hematologic side effects have included eosinophilia, leukopenia, monocytosis, and pancytopenia with or without bone marrow suppression.

Gastrointestinal

Gastrointestinal side effects have included nausea, vomiting, anorexia, diarrhea, weight loss, epigastric and abdominal pain, and constipation.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.